MULTIPLE MYELOMA WITH FAILED REMISSION
Clinical trials for MULTIPLE MYELOMA WITH FAILED REMISSION explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA WITH FAILED REMISSION trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA WITH FAILED REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough myeloma: early trial of HPN217 begins
Disease control OngoingThis early-stage study is testing a new drug called HPN217 in about 100 people whose multiple myeloma has returned or stopped responding to standard treatments. The main goal is to check the drug's safety and find the best dose. Researchers will also measure how the drug moves th…
Matched conditions: MULTIPLE MYELOMA WITH FAILED REMISSION
Phase: PHASE1 • Sponsor: Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
Website aims to empower myeloma patients in their own treatment
Knowledge-focused OngoingThis study looks at whether a health technology program called All4Cure helps people with multiple myeloma become more active in managing their health. About 200 participants will fill out surveys online to measure their confidence and ability to handle their care. The goal is to…
Matched conditions: MULTIPLE MYELOMA WITH FAILED REMISSION
Sponsor: All4Cure • Aim: Knowledge-focused
Last updated May 26, 2026 12:02 UTC